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The enzyme al,3-galactosyltransferase (al,3GT or GGTA1) synthesizes al,3-
galactose (al.3Gal) epitopes (Galal,3Galr31,4GlcNAc-R), which are the major 
xenoantigens causing hyperacute rejection in pig-to-human xenotransplanta-
tion. Complete removal of a 1 ,3Gal from pig organs is the critical step toward 
the success of xenotransplantation. We reported earlier the targeted disruption 
of one allele of the a 1 ,3GT gene in cloned pigs. A selection procedure based on 
a bacterial toxin was used to select for cells in which the second allele of the 
gene was knocked out, Sequencing analysis demonstrated that knockout of the 
second allele of the a 1 ,3GT gene was caused by a T -to-G single point mutation 
at the second base of exon 9, which resulted in inactivation of the al,3GT 
protein. Four healthy a 1 ,3GT double-knockout female piglets were produced by 
three consecutive rounds of cloning. The piglets carrying a point mutation in 
the a l,3GT gene hold significant value, as they would allow production of 
a' ,3Gal-deficient pigs free of antibiotic-resistance genes and thus have the 
potential to make a safer product for human use. 
The enzyme a I ,3-galactosyltransferase 
(al,3GT or GGTAI) synthesizes al,3Gal 
epitopes (Galal,3Galr3I,4GlcNAc-R) on the 
cell surface of almost all mammals with the 
exception of humans, apes, and Old World 
monkeys (1). al,3Gal epitopes are the major 
xenoantigens causing hyperacute rejection 
(HAR) in pig-to-human xenotransplantation 
(2-4). Many reports have also indicated that 
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al,3Gal epitopes are involved in acute vas-
cular rejection (AVR) of xenografts (4-6). 
Piglets with al,3GT heterozygous knockout 
have been cloned by our group (7) and 
another team (8) in the last year. To produce 
homozygous al,3GT knockout piglets by 
natural breeding, assuming both male and 
female heterozygous knockout pigs are avail-
able at the same time and are fertile, is 
feasible but takes up to 12 months. However, 
by using a second-round knockout and clon-
ing strategy, we could save up to 6 months 
and all cloned piglets would be a 1 ,3GT 
double knockout (DKO). We have selected 
and enriched for al,3GT DKO cells by using 
a bacterial toxin, toxin A from Clostridium 
difJicile, which binds with high affinity to 
a I ,3Gal epitopes and produces a cytotoxic 
effect on cells that are a I ,3Gal-positive (9). 
Toxin A uses al,3GaJ epitopes as a cell 
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surface receptor and causes "rounding" and 
lifting of the cd,3Gal-positive cells from the 
surface of the growth vessel (10, 11). 
Heterozygous Ci I ,3GT knockout fetal fi-
broblasts, 657 A-Ill 1-6 cells, were isolated 
from a day-32 pregnancy as described in (7). 
To avoid using a second antibiotic-resistance 
gene as a selection marker, we constructed an 
ATG (start codon)-targeting CiI,3GT knock-
out vector, pPL680 (12), which also contains 
a neo gene, to knock out the second allele of 
the Cil,3GT gene. 657A-IlI 1-6 cells were 
transfected by electroporation with pPL680 
and selected for the Ci 1,3Gal-negative pheno-
type with purified C. difficile toxin A (13). 
One colony (680B I) was isolated and ex-
panded after toxin A selection. When the 
680B I cells were stained with a fluoreseein-
labeled CiI,3Gal-specific lectin, GS-lB4, 
about 80% of the cells were found to be 
exl,3Gal-negative. The fact that fewer than 
100% of the cells in the colony were negative 
with GS-lB4 staining indicated that this col-
ony contained a mixture of CiI,3Gal-negative 
and -positive cells. We used 680B I cells for 
somatic cell nuclear transfer (cloning) as de-
scribed in (7). We transferred embryos to five 
recipient gilts, and three initial pregnancies 
were established, of which only one went 
beyond day 35 of gestation. 
To determine whether all the fetuses 
cloned from 680B I cells were Ci I ,3GT DKO, 
we terminated the remaining pregnancy at 
day 39 and recovered four normal-sized fe-
tuses. Fibroblast cell lines (680BI-I to BI-4) 
were isolated from each of these four fetuses, 
and fluorescence-activated cell sorting 
(FACS) analysis with GS-lB4 staining 
showed that BI-I, BI-2, and BI-4 cells were 
Cil,3Gal-negative, whereas BI-3 cells were 
positive for Cil,3Gal (Fig. 1). Normal human 
serum (NHS) contains preformed antibodies 
to cd,3Gal and complement proteins, which 
together cause rapid lysis of cells that are 
CiI,3Gal-positive. A complement lysis assay 
on these cells showed that BI-l, BI-2, and 
B 1-4 cells were resistant to lysis by NBS, but 
BI-3 cells were lysed by NHS at the same 
rate (about 40% of cells lysed) as control 
wild-type pig cells (Fig. 2). Analysis of 
genomic DNA from these fetal cells by poly-
merase chain reaction (PCR) and Southern 
blot analysis indicated that none of the three 
ex I ,3Gal-negative cell lines had the expected 
restriction fragment pattern predicted for tar-
geted disruption of the second Ci I ,3GT allele 
with the pPL680 knockout vector. Instead, 
these fetal cells appeared to have the same 
allele pattern (one targeted allele and one 
wild-type allele) as their parent 657 A-Ill 1-6 
celis, which contained only OIlC disrupted 
ex 1 ,3GT allele. Northern blot analysis of the 
four cell lines (BI-1 to BI-4) showed that 
they expressed two mRNAs of similar size to 
those secll in thc 657A-lll 1-6 cells (fig. SI). 
The 3.8-kb band corresponds in size to the 
wild-type Ci I ,3GT transcript and the shorter 
2.5-kb band is the same size expected for the 
truncated transcript of the first knockout al-
lele (fig. S I). Because of the nature of the 
toxin A selection method, CiI,3Gal-negative 
cells are selected, regardless of whether inac-
tivation of the second od,3GT allele was 
caused by targeted disruption via the pPL680 
vector or by any other mechanism. The fact 
that one normal-sized allele was observed 
(instead of two shorter knockout alleles) in-
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dicated that knockout of the second al,3GT 
allele was due to mechanisms other thall tar-
geted homologous recombination-mediated 
disruption, promoter dysfunction, or mRNA 
missplicing and instability. 
To identify the nature of the inactivation 
event for the second allele, we subcloned and 
sequenced al,3GT cDNAs from all four cell 
lines (B I-I, Bl-2, B 1-3, and B 1-4). Sequenc-
ing results revcaled that there was a T -to-G 
transversion at the second base pair of exon 9 
in the nontargeted Ci I ,3GT allele of B 1-1, 
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Fig. 1. Flow cytometry analysis of 680B 1-1 to B 1-4 cells with GS-IB4lectin staining. Horizontal and 
vertical axes denote intensity of fluorescence and number of events, respectively. Dotted line 
represents unstained cells analyzed by a fluorescence-activated cell sorter (Becton-Dickenson, 
Franklin, NJ). Shadow represents cells stained with fluorescein isothiocyanate-labeled GS-I-B4 
lectin (EY Laboratories, Inc., San Mateo, CAl. B1-1, Bl-2, Bl-3, and Bl-4 are fetal fibroblasts derived 
from four day-39 fetuses. HeLa cells, a human cell line, were used as the negative control and 
PCFF4-6 cells, which were the parent cells for heterozygous and DKO of the a1,3GT gene, were 
used as the positive control. 
Fig. 2. Complement 
lysis assay for DKO fe-
tal fibroblasts and 
wild-type pig cells. Re-
sults are the average 
of three individual as-
says. Open box repre- .5 
sents NHS. Solid box ~ 
represents heat-inac- -; 
tivated human serum U 
(HIA-HS) as the nega- -; 
tive control. and .... 
hatched box repre- ~ 
sents bovine serum al- ~ 
bumin (BSA) as the re- Q 
agent control. About 
20% calcein release 
(no cells lysed) is the 
base value for the 
negative control (HIA-
HS) and the reagent 
control (BSA). For 
quality control and re-
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producibility purposes, we did not use fresh human serum for the assay, which usually gives about 
90% calcein release. About 50% calcein release (about 40% of cells lysed) from wild-type pig cells 
is typical with commercial serum (frozen and lyophilized) from Sigma. 
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BI-2, and BI-4 cells, but not in BI-3 cells or 
in the first knockout allele of all four cell 
lines. This T -to-G transversion in the u I ,3GT 
coding region caused a single amino acid 
change from tyrosine to aspartic acid in the 
a I ,3GT protein (Fig. 3). Although this muta-
tion has not been obscrved in the inactivated 
a I JGT gene of humans or higher primates 
(14), it is likely that the change of tyrosine, a 
hydrophobic amino acid, to aspartic acid, a 
hydrophilic amino acid, could disrupt 
a I ,3GT function. Crystal structure analysis 
of bovine u 1,3GT protein supports this spec-
ulation and shows that this tyrosine is at the 
center of the catalytic domain of bovine 
al,3GT protein and is involved in uridine 
5'-diphosphate-Gal binding (/5,16). 
To further confirm that the mutated cDNA 
cannot make functional a 1 ,3GT protcin, we 
cloncd al,3GT cDNAs from the nontargeted 
allele of B I-I to B 1-4 cells and wild-type pig 
cells into an expression vector and transfected 
them into human HeLa cells, which normally 
do not express u I ,3GT protein. HeLa cells 
transfected with cDNA expression vectors from 
B 1-1, B 1-2, and B 1-4 cells were negative for 
GS-1B4lectin staining, indicating that the trans-
fccted pig cDNA from these cells did not make 
functional a I ,3GT protein. In contrast, HeLa 
cells transfected with the eDNA from B 1-3 
cells and wild-type pig cells were positive with 
GS-IB4 staining. These results verified that the 
point mutation in eDNA from the second allele 
of the al,3GT gene in BI-I, BI-2, and BI-4 
cells resulted in synthesis of a defective u I ,3GT 
protein. Although toxin A selection was repeat-
ed several times on 657 A-I I I 1-6 cells, with or 
without pPL680 vector transfection, no addi-
tional toxin A-resistant colonies were detected. 
We performed somatic cell nuclear trans-
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Fig. 3. Sequencing analysis of the a l,3GT gene 
from wild-type pig cells and DKO porcine fetal 
fibroblasts. Upper and lower alignment show 
nucleotide sequence of the a 1.3GT intron 
8-exon 9 boundary from wild-type pigs and 
the second allele of the DKO pig fetuses (B 1-1, 
Bl-2, and Bl -4), respectively. Small letters and 
capital letters denote intron and exon sequenc-
es, respectively. Underlined capital letters indi-
cate the nucleotide where the point mutation 
occurred. Amino acids deduced from the corre-
spondent mutated and wild-type DNA se-
quence are underlined. No other mutations 
were found in the coding region of the (X 1 ,3GT 
gene from the second allele of the DKO pig 
fetuses in our genomic and reverse transcript-
ase-PCR libraries. 
fer (cloning) with all three DKO cell lines as 
described in (7). We transferred cloned em-
bryos into 16 estrus-synchronized recipient 
gilts. Ten initial pregnancies were estab-
lished. only two of which went to term. Two 
pregnancies were lost before day 30, five 
were lost between day 30 and day 40, and one 
was lost by day 60_ The first five female 
ul,3GT DKO piglets (761-1 to 761-5), 
cloned from 680BI-2 cells, were born on 25 
July 2002. One piglet (761-1) died shortly 
after birth, and necropsy revealed an enlarged 
tongue and unusually large kidneys. We have 
observed this phenotype in a few other 
ul,3Gal-positive cloned pigs, and it appcars 
to be a function of the cloning process (in-
complete reprogramming) and not the 
al,3GT gene knockout per se, The other four 
DKO piglets were of normal size and healthy. 
Aorta endothelial cells and muscle and tail 
fibroblasts isolated from the dead piglet (761-
I) were negative with GS-IB4lectin staining. 
F ACS analysis of muscle fibroblasts from 
piglct 761-1 also showed a negative result for 
GS-IB4 binding. Neonatal tail fibroblasts iso-
lated from the four healthy piglets, when 
analyzed by FACS with GS-IB4, were all 
negative (fig. S2). Tissue sections of liver, 
kidney, spleen, skin, intestine, muscle, brain, 
heart, pancreas, lung, aorta, tongue, umbili-
cus, and tail obtained from piglet 761-1 were 
all negative with GS-IB4 staining, indicating 
a complete lack of detectable cell surface 
a I ,3Gal epitopes. The GS-1B4 staining re-
sults for liver sections from a newborn wild-
type piglet and from piglet 761-1 are shown 
in fig. S3. Southern blot and sequencing anal-
ysis of DNA samples from all five piglets 
confirmed the targeted disruption of the first 
allele of the a 1 ,3GT gene and the T -to-G 
point mutation in the second base of exon 9 in 
the second allele of the al,3GT gene. It has 
been reported that a 1 ,3GT DKO mice devel-
oped cataracts at 4 to 6 weeks of age (17). 
Physical examination of the four piglets at 7 
weeks of age did not rcveal any abnormalities 
or cataracts. We will continue to monitor the 
piglets for the presence of cataracts. 
We performed an in vivo immunogenicity 
test with a 1 ,3GT -knockout mice. We inject-
ed islet-like cell clusters (ICCs) isolated from 
the pancreas of piglet 761-1 intraperitoneally 
into al,3GT knockout mice. We used ICCs 
from a neonatal wild-type piglet as a control. 
As shown in fig. S4, no increase in the titer of 
immunoglobulin M (lgM) to al,3Gal was 
observed in a 1,3GT knockout mice after in-
jection with ICCs from the u 1 ,3GT DKO 
piglet, in contrast to significant IgM titer 
increases observed in those mice injected 
with wild-type piglet ICCs, This result clear-
ly demonstrates that the DKO piglet cells do 
not make any a I ,3Gal epitopes. 
Thus, we have successfully produced four 
a I ,3GT -deficient piglets by a toxin A-medi-
REPORTS 
ated selection method. Although our intent 
was to knock out the second allele of the 
ul,3GT gene by homologous recombination, 
this did not occur. Instead, because we used 
this powerful selection method, which allows 
us to isolate any event that results in loss of 
al,3GT activity, we discovered a mutation in 
the second allele of the al,3GT gene. Had we 
used standard selection methods with puro-
mycin or hygromycin, we would not have 
found the mutation. Although the rate of 
spontaneous mutation in the pig genome is 
very low [about 4 X 10 -8 for a spontaneous 
mutation per replication (18) in a mammalian 
gene similar in size to the a 1 ,3GT gene], 
toxin A selection still enabled us to detect this 
crucial mutation. Clearly inactivation of the 
a 1 ,3GT protein by this point mutation is a 
better outcome than by gene targeting with 
the pPL680 vector. It provides the opportu-
nity to produce al,3GT-deficient pigs with-
out any antibiotic-resistance genes or other 
foreign DNA sequences, which should facil-
itate regulatory approval and, potentially, 
make a safer product for human use. It is 
certain that this point mutation will be main-
tained in the genome of these DKO pigs and 
their offspring, just as the few critical point 
mutations in the a 1 ,3GT gene of humans and 
higher primates have been maintained over 20 
million years (14). This genomic stability is not 
only due to the rarity of a reverse mutation 
event [about 5 X 10 - 11 per replication (18) for 
mammals] but, more importantly, the strong 
selection pressure against al,3Gal-positive 
cells by the presence of antibodies to u I ,3 Gal in 
a I ,3Gal-negative animals. Our results have 
demonstrated that removal of al,3Gal epitopcs 
on pig cells did not preclude development in 
utero, even though pig cells express up to 500 
times the number of a 1 JGal epitopes as do 
mouse cells (4, 19). In addition, three consecu-
tive rounds of cloning with rederived fetal cells 
did not appear to have a major detrimental 
effect on the overall development or health of 
the cloned pigs in this study. Analysis of tissues 
and organs from these u I ,3GT DKO pigs in 
nonhuman primate models should provide clear 
indications of the involvement of a I ,3Gal in 
HAR, A YR, and chronic rejection. 
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